Evaluation of thyroid dysfunction as a candidate surrogate marker for efficacy of sunitinib in patients (pts) with advanced renal cell cancer (RCC)

被引：13
|
作者：
Wolter, P.
Stefan, C.
Decallonne, B.
Dumez, H.
Fieuws, S.
Wildiers, H.
Clement, P.
Debaere, D.
Van Oosterom, A.
Schoffski, P.
机构：
[1] Katholieke Univ Leuven Hosp, Louvain, Belgium
[2] Catholic Univ Louvain, B-3000 Louvain, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5126
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?
    Ha, Vincent H.
    Ngo, Margaret
    Chu, Michael P.
    Ghosh, Sunita
    Sawyer, Michael B.
    Chambers, Carole R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (03) : 194 - 200
  • [22] Influence of risk factors for renal cell carcinoma (RCC) on outcome of patients (pts) with metastatic disease treated with sunitinib.
    Keizman, Daniel
    Ish-Shalom, Maya
    Taksey, Jason David
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Boursi, Ben
    Berger, Raanan
    Maimon, Natalie
    Gottfried, Maya
    Hayat, Henry
    Peer, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Carducci, Michael Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [23] NOVEL CIRCULATING PROTEINS, SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS), AND MOLECULAR TUMOR MARKERS AS POTENTIAL BIOMARKERS OF SUNITINIB EFFICACY IN TREATMENT-NAiVE PATIENTS (PTS) WITH ADVANCED RENAL CELL CARCINOMA (RCC)
    Motzer, R. J.
    Hutson, T. E.
    Hudes, G. R.
    Figlin, R. A.
    Martini, J.
    English, P. A.
    Wood, L.
    Huang, X.
    Valota, O.
    Williams, J. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 262 - 262
  • [24] Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): depth of response and efficacy for selected subgroups in the lenvatinib (L) plus pembrolizumab (P) and sunitinib (S) treatment arms
    Gruenwald, Viktor
    Powles, Thomas
    Kopyltsov, Evgeny
    Kozlov, Vadim
    Gordoa, Teresa Alonso
    Eto, Masatoshi
    Hutson, Thomas
    Motzer, Robert
    Winquist, Eric
    Maroto, Pablo
    Keam, Bhumsuk
    Procopio, Giuseppe
    Wong, Shirley
    Melichar, Bohuslav
    Rolland, Frederic
    Oya, Mototsugu
    Rodriguez-Lopez, Karla
    Saito, Kenichi
    Smith, Alan
    Porta, Camillo
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 104 - 105
  • [25] TSH ELEVATION AS MARKER OF EFFICACY IN SUNITINIB RECEIVING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Baldazzi, Valentina
    Tassi, Renato
    Lapini, Alberto
    Caruso, Salvatore
    Cipriani, Greta
    Diacciati, Sara
    Cerullo, Carmine
    Brogi, Lorenzo
    Santomaggio, Carmine
    Carini, Marco
    Mazzanti, Roberto
    ANTICANCER RESEARCH, 2010, 30 (04) : 1447 - 1448
  • [26] Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): depth of response and efficacy for selected subgroups in the lenvatinib (L) plus pembrolizumab (P) and sunitinib (S) treatment arms
    Gruenwald, V
    Powles, T.
    Kopyltsov, E.
    Kozlov, V
    Alonso, Gordoa T.
    Eto, M.
    Hutson, T.
    Motzer, R.
    Winquist, E.
    Maroto, P.
    Keam, B.
    Procopio, G.
    Wong, S.
    Melichar, B.
    Rolland, F.
    Oya, M.
    Rodriguez-Lopez, K.
    Saito, K.
    Smith, A.
    Porta, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 25 - 25
  • [27] The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Safety and efficacy in patients (pts) with non-clear cell (NCC) renal cell carcinoma (RCC)
    Stadler, W. M.
    Figlin, R. A.
    Ernstoff, M. S.
    Curti, B.
    Pendergrass, K.
    Srinivas, S.
    Canfield, V.
    Weissman, C.
    Poulin-Costello, M.
    Bukowski, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] A PILOT STUDY OF THE SAFETY, EFFICACY, AND EFFECTS ON FUNCTIONAL IMAGING OF THE COMBINATION OF cG250 AND SUNITINIB IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC)
    Davis, I.
    Ciprotti, M.
    Lee, F.
    Pook, D.
    Cavicchiolo, T.
    Lee, S.
    Chappell, B.
    O'Keefe, G.
    Tochon-Danguy, H.
    Hopkins, W.
    Scott, A.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 11 - 11
  • [29] Predictive radiomics signature for treatment response to nivolumab in patients (pts) with advanced renal cell carcinoma (RCC)
    Sim, H-W.
    Stundzia, A.
    Pierre, S.
    Metser, U.
    O'Malley, M.
    Elimova, E.
    Sridhar, S. S.
    Hansen, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] Incidence and risk of congestive heart failure risk in renal cell cancer (RCC) and non-RCC patients treated with sunitinib
    Richards, C. J.
    Je, Y.
    Schutz, F. A.
    Dallabrida, S. M.
    Moslehi, J. J.
    Choueiri, T. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
12345